Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter.
McCabe C, White PA, Hoole SP, Axell RG, Priest AN, Gopalan D, Taboada D, MacKenzie Ross R, Morrell NW, Shapiro LM, Pepke-Zaba J. McCabe C, et al. Among authors: axell rg. J Appl Physiol (1985). 2014 Feb 15;116(4):355-63. doi: 10.1152/japplphysiol.01123.2013. Epub 2013 Dec 19. J Appl Physiol (1985). 2014. PMID: 24356516 Free PMC article.
Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization.
McCormick LM, Hoole SP, White PA, Read PA, Axell RG, Clarke SJ, O'Sullivan M, West NEJ, Dutka DP. McCormick LM, et al. Among authors: axell rg. JACC Cardiovasc Interv. 2015 Feb;8(2):292-301. doi: 10.1016/j.jcin.2014.09.014. JACC Cardiovasc Interv. 2015. PMID: 25700752 Free article. Clinical Trial.
Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies.
Giblett JP, Axell RG, White PA, Clarke SJ, McCormick L, Read PA, Reinhold J, Brown AJ, O'Sullivan M, West NE, Dutka DP, Hoole SP. Giblett JP, et al. Among authors: axell rg. Cardiovasc Diabetol. 2016 Jul 19;15:99. doi: 10.1186/s12933-016-0416-3. Cardiovasc Diabetol. 2016. PMID: 27431258 Free PMC article. Clinical Trial.
Glucagon-Like Peptide-1-Mediated Cardioprotection Does Not Reduce Right Ventricular Stunning and Cumulative Ischemic Dysfunction After Coronary Balloon Occlusion.
Giblett JP, Axell RG, White PA, Aetesam-Ur-Rahman M, Clarke SJ, Figg N, Bennett MR, West NEJ, Hoole SP. Giblett JP, et al. Among authors: axell rg. JACC Basic Transl Sci. 2019 Apr 29;4(2):222-233. doi: 10.1016/j.jacbts.2018.12.002. eCollection 2019 Apr. JACC Basic Transl Sci. 2019. PMID: 31061924 Free PMC article.
Functional assessment and transplantation of the donor heart after circulatory death.
Messer SJ, Axell RG, Colah S, White PA, Ryan M, Page AA, Parizkova B, Valchanov K, White CW, Freed DH, Ashley E, Dunning J, Goddard M, Parameshwar J, Watson CJ, Krieg T, Ali A, Tsui S, Large SR. Messer SJ, et al. Among authors: axell rg. J Heart Lung Transplant. 2016 Dec;35(12):1443-1452. doi: 10.1016/j.healun.2016.07.004. Epub 2016 Jul 16. J Heart Lung Transplant. 2016. PMID: 27916176
21 results